Alpha Tau Medical Ltd (NASDAQ:DRTS) — Market Cap & Net Worth
Market Cap & Net Worth: Alpha Tau Medical Ltd (DRTS)
Alpha Tau Medical Ltd (NASDAQ:DRTS) has a market capitalization of $614.75 Million ($614.75 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11245 globally and #2918 in its home market, demonstrating a 1.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alpha Tau Medical Ltd's stock price $15.04 by its total outstanding shares 85264146 (85.26 Million). Also see how large is Alpha Tau Medical Ltd's balance sheet for a full breakdown of the balance sheet.
Alpha Tau Medical Ltd Market Cap History: 2021 to 2026
Alpha Tau Medical Ltd's market capitalization history from 2021 to 2026. Data shows growth from $837.29 Million to $1.28 Billion (7.47% CAGR). Also see DRTS cash flow metrics for how efficiently the company converts equity into cash flow.
Index Memberships
Alpha Tau Medical Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.02% | #311 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #1144 of 3165 |
Weight: Alpha Tau Medical Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alpha Tau Medical Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alpha Tau Medical Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check DRTS share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DRTS by Market Capitalization
Companies near Alpha Tau Medical Ltd in the global market cap rankings as of September 18, 2026. Review DRTS goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Alpha Tau Medical Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Alpha Tau Medical Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Alpha Tau Medical Ltd's market cap moved from $837.29 Million to $ 1.28 Billion, with a yearly change of 7.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.28 Billion | +203.84% |
| 2025 | $422.06 Million | +59.68% |
| 2024 | $264.32 Million | +2.99% |
| 2023 | $256.65 Million | -5.35% |
| 2022 | $271.14 Million | -67.62% |
| 2021 | $837.29 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Alpha Tau Medical Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.75 Million USD |
| MoneyControl | $614.75 Million USD |
| MarketWatch | $614.75 Million USD |
| marketcap.company | $614.75 Million USD |
| Reuters | $614.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending cl… Read more